Introduction {#tca13052-sec-0005}
============

Lung cancer is the leading cause of cancer‐related death of both men and women worldwide.[1](#tca13052-bib-0001){ref-type="ref"}, [2](#tca13052-bib-0002){ref-type="ref"}, [3](#tca13052-bib-0003){ref-type="ref"}, [4](#tca13052-bib-0004){ref-type="ref"}, [5](#tca13052-bib-0005){ref-type="ref"}, [6](#tca13052-bib-0006){ref-type="ref"}, [7](#tca13052-bib-0007){ref-type="ref"}, [8](#tca13052-bib-0008){ref-type="ref"}, [9](#tca13052-bib-0009){ref-type="ref"} Poor survival is associated with tumor metastasis.[10](#tca13052-bib-0010){ref-type="ref"}, [11](#tca13052-bib-0011){ref-type="ref"}, [12](#tca13052-bib-0012){ref-type="ref"}, [13](#tca13052-bib-0013){ref-type="ref"}, [14](#tca13052-bib-0014){ref-type="ref"}, [15](#tca13052-bib-0015){ref-type="ref"} Lung cancer metastasis is not only the malignant marker but is the main cause of treatment failure.[16](#tca13052-bib-0016){ref-type="ref"}, [17](#tca13052-bib-0017){ref-type="ref"}, [18](#tca13052-bib-0018){ref-type="ref"}, [19](#tca13052-bib-0019){ref-type="ref"}, [20](#tca13052-bib-0020){ref-type="ref"} Metastasis is a complex biological behavior that is correlated with many factors, genes, signal pathways, and biological processes.[21](#tca13052-bib-0021){ref-type="ref"}, [22](#tca13052-bib-0022){ref-type="ref"}, [23](#tca13052-bib-0023){ref-type="ref"}, [24](#tca13052-bib-0024){ref-type="ref"}, [25](#tca13052-bib-0025){ref-type="ref"}, [26](#tca13052-bib-0026){ref-type="ref"} Therefore, exploration of changes to molecular genetics and cell signal transduction related to invasion and metastasis in lung cancer will not only illuminate the molecular mechanisms of tumor invasion and metastasis, but also provide a new targeting molecule and route for blocking signal transduction and reversing the metastatic phenotype of lung cancer.[27](#tca13052-bib-0027){ref-type="ref"}, [28](#tca13052-bib-0028){ref-type="ref"}, [29](#tca13052-bib-0029){ref-type="ref"}, [30](#tca13052-bib-0030){ref-type="ref"}, [31](#tca13052-bib-0031){ref-type="ref"}, [32](#tca13052-bib-0032){ref-type="ref"} Our previous studies showed that low expression and hetero‐deletion of tumor metastasis suppressor gene *nm23‐H1* are closely correlated with high metastatic ability and poor prognosis in lung cancer patients.[25](#tca13052-bib-0025){ref-type="ref"}, [26](#tca13052-bib-0026){ref-type="ref"}, [27](#tca13052-bib-0027){ref-type="ref"}, [28](#tca13052-bib-0028){ref-type="ref"}, [29](#tca13052-bib-0029){ref-type="ref"}, [30](#tca13052-bib-0030){ref-type="ref"}, [31](#tca13052-bib-0031){ref-type="ref"}, [32](#tca13052-bib-0032){ref-type="ref"}, [33](#tca13052-bib-0033){ref-type="ref"}, [34](#tca13052-bib-0034){ref-type="ref"} We also demonstrated that transfection of wild type *nm23‐H1* complementary DNA (cDNA) into human high‐metastatic large cell lung cancer cells (which exhibit loss of heterozygosity \[LOH\] of *nm23‐H1*), can regulate the expression of metastatic relative genes and reverse the metastatic phenotype of lung cancer cell lines.[23](#tca13052-bib-0023){ref-type="ref"}, [24](#tca13052-bib-0024){ref-type="ref"}, [25](#tca13052-bib-0025){ref-type="ref"}, [26](#tca13052-bib-0026){ref-type="ref"}, [27](#tca13052-bib-0027){ref-type="ref"}, [28](#tca13052-bib-0028){ref-type="ref"}, [29](#tca13052-bib-0029){ref-type="ref"}, [30](#tca13052-bib-0030){ref-type="ref"} Our findings and other reports have provided sufficient evidence to indicate that *nm23‐H1* is a metastasis suppressor gene in many tumors.[21](#tca13052-bib-0021){ref-type="ref"}, [22](#tca13052-bib-0022){ref-type="ref"}, [23](#tca13052-bib-0023){ref-type="ref"}, [24](#tca13052-bib-0024){ref-type="ref"}, [25](#tca13052-bib-0025){ref-type="ref"}, [26](#tca13052-bib-0026){ref-type="ref"}, [27](#tca13052-bib-0027){ref-type="ref"}, [28](#tca13052-bib-0028){ref-type="ref"}, [29](#tca13052-bib-0029){ref-type="ref"}, [30](#tca13052-bib-0030){ref-type="ref"}, [31](#tca13052-bib-0031){ref-type="ref"}, [32](#tca13052-bib-0032){ref-type="ref"}, [33](#tca13052-bib-0033){ref-type="ref"}, [34](#tca13052-bib-0034){ref-type="ref"}, [35](#tca13052-bib-0035){ref-type="ref"}, [36](#tca13052-bib-0036){ref-type="ref"}, [37](#tca13052-bib-0037){ref-type="ref"} Our studies have also proven that the *nm23‐H1* gene is a key and upstream regulative gene in the "lung cancer metastatic suppressive cascade."[23](#tca13052-bib-0023){ref-type="ref"}, [24](#tca13052-bib-0024){ref-type="ref"}, [25](#tca13052-bib-0025){ref-type="ref"}, [26](#tca13052-bib-0026){ref-type="ref"}, [27](#tca13052-bib-0027){ref-type="ref"}, [28](#tca13052-bib-0028){ref-type="ref"}, [29](#tca13052-bib-0029){ref-type="ref"}, [30](#tca13052-bib-0030){ref-type="ref"}, [31](#tca13052-bib-0031){ref-type="ref"}, [32](#tca13052-bib-0032){ref-type="ref"}, [33](#tca13052-bib-0033){ref-type="ref"} However, the exact molecular mechanism by which *nm23‐H1* suppresses or reverses lung cancer metastasis is unclear.

Mitochondria are important organelles in cellular physiology. They have their own genomic system independent from the nucleus, and possess their own transcription, translation, and protein assembly machinery.[13](#tca13052-bib-0013){ref-type="ref"}, [38](#tca13052-bib-0038){ref-type="ref"}, [39](#tca13052-bib-0039){ref-type="ref"}, [40](#tca13052-bib-0040){ref-type="ref"}, [41](#tca13052-bib-0041){ref-type="ref"}, [42](#tca13052-bib-0042){ref-type="ref"}, [43](#tca13052-bib-0043){ref-type="ref"}, [44](#tca13052-bib-0044){ref-type="ref"}, [45](#tca13052-bib-0045){ref-type="ref"}, [46](#tca13052-bib-0046){ref-type="ref"}, [47](#tca13052-bib-0047){ref-type="ref"} They are the principal suppliers of adenosine triphosphate, playing a central role in cellular energy metabolism and apoptosis. The oxidative metabolism of mitochondria contributes to harmful protein modifications, even under normal conditions.[39](#tca13052-bib-0039){ref-type="ref"}, [40](#tca13052-bib-0040){ref-type="ref"}, [41](#tca13052-bib-0041){ref-type="ref"} Mitochondrial function changes have been implicated in tumor formation, including increased production of reactive oxygen species (ROS), decreased oxidative phosphorylation, and a corresponding increase in glycolysis.[13](#tca13052-bib-0013){ref-type="ref"}, [41](#tca13052-bib-0041){ref-type="ref"}, [42](#tca13052-bib-0042){ref-type="ref"}, [43](#tca13052-bib-0043){ref-type="ref"} Recently, deregulated cellular energetics have been considered an additional emerging hallmark of cancer.[13](#tca13052-bib-0013){ref-type="ref"} Cancer cell signaling regulated by kinases and phosphatases is guided by cellular redox status and may be key in malignant transformation.

The protection of mitochondrial protein function is an important aspect of cellular protein quality control. However, mitochondrial proteins are difficult to characterize because of their relatively low abundance. Subcellular proteomic research would represent a significant advancement in the profiling of mitochondrial changes in diseased cells.[43](#tca13052-bib-0043){ref-type="ref"} Two‐dimensional differential in gel electrophoresis (2D‐DIGE), coupled with matrix assisted laser desorption‐ionization‐time of flight (MALDI‐TOF) mass spectrometry (MS) has is frequently been applied in this field.[29](#tca13052-bib-0029){ref-type="ref"}, [30](#tca13052-bib-0030){ref-type="ref"}, [44](#tca13052-bib-0044){ref-type="ref"} However, mitochondrial proteomic profiles in non‐small cell lung cancer (NSCLC) remain poorly defined, particularly related to lung cancer metastasis. We conducted differential profiling of mitochondrial proteins from NSCLC cell lines with high and low metastatic potential and analyzed mitochondria‐related metabolic pathways to identify the possible molecular markers of NSCLC metastasis.

Methods {#tca13052-sec-0006}
=======

Cell lines and reagents {#tca13052-sec-0007}
-----------------------

A human high metastatic large cell lung cancer cell line (L9981) and low metastatic large cell lung cancer cell line (NL9980) were established from a human lung large cell carcinoma cell line (WCQH‐9801) in our laboratory.[48](#tca13052-bib-0048){ref-type="ref"} Cell lines were cultured in RMPI 1640 medium containing 10% fetal bovine serum (Gibco, Grand Island, NY, USA) at 37°C with 5% CO~2~ incubator. Cy2, Cy3, and Cy5 were purchased from GE Healthcare (Piscataway, NJ, USA). Immobiline pH‐gradient (IPG) DryStrips (pH 3--10,24 cm), IPG buffer (pH 3--10), DryStrip cover fluid, thiourea, urea, dithiothreitol (DTT) , Pharmalyte (pH 3‐10), bromophenol blue, Commassie Brilliant Blue G‐250, Tris base, sodium dodecyl sulfate (SDS), and molecular weight marker were purchased from Amersham Biosciences (Uppsala, Sweden).

Modified trypsin (sequencing grade) was obtained from Promega (Madison, IL, USA). Sucrose and mannitol were purchased from Sango (Shanghai, China). All analytical grade chemicals and biochemicals were prepared with Milli‐Q deionized water (Millipore, Bedford, MA, USA).

Primary anti‐fumarate hydratase (sc‐27995), PRDX3 (sc‐23969), HSP75 (TR1) (sc‐13557), ERAB (sc‐58525), PCNA (sc‐56), and cytochrome c (SC‐13560) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), and anti‐PHB (\#2426) and COX IV (\#4844) antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA).

Isolation and purification of mitochondria {#tca13052-sec-0008}
------------------------------------------

Cells were collected by centrifugation at 700 g for 10 minutes and the pellets were resuspended in homogenization medium A (20 mM Hepes‐KOH, 1 mM ethylene‐diamine‐tetraacetic acid \[EDTA\], 1 mM phenylmethylsulfonyl fluoride \[PMSF\], 50 mM sucrose, 200 mM mannitol, pH7.4). The suspension was left on ice for 10 minutes. Cells were then dounce‐homogenized and the lysis was monitored for quality by using phase‐contrast microscopy until at least 90% of the cells were broken. The homogenate was centrifuged at 1000g for 10 minutes at 4°C and supernatant A was collected. The pellets were then washed twice with homogenization Medium B (20 mM Hepes‐KOH, 25 mM KCl, 5 mM MgCl~2~, 1 mM PMSF, 250 mM sucrose, pH7.4), and saved as the nuclear fraction. Supernatant A was centrifuged at 12 500g for 15 minutes at 4°C, and the pellet was collected and then washed once as a heavy membrane pellet. The heavy membrane pellet was resuspended in homogenization Medium A and spun again at 4000 g for 15 minutes to obtain the heavy mitochondrial pellet.

The heavy mitochondrial pellet was overlaid on a sucrose step density gradient (1.0 M sucrose over 1.5 M sucrose in 10 mM Tris_HCl \[pH 7.4\], 1 mM EDTA). The preparation was ultracentrifuged at 60 000 g for 20 minutes at 4°C to obtain mitochondria‐enriched pellets. The pellets were washed twice in homogenization medium A.

Sodium dodecyl sulfate‐polyacrylamide gel electrophoresis {#tca13052-sec-0009}
=========================================================

The mitochondria‐enriched pellets were suspended in the loading buffer (50 mM Tris‐HCl, pH 6.8, 100 mM DTT, 2% SDS, 0.1% bromophenol blue, 10% glycerol) and run on SDS‐polyacrylamide gel electrophoresis (PAGE, T = 12%) in Tris‐glycine running buffer with 50 ug of protein per lane.

Western blot analysis {#tca13052-sec-0010}
---------------------

The mitochondria proteins were transferred to nitrocellulose membrane (Amersham Biosciences) under wet conditions at 80 V for two hours. Blots were blocked with blocking buffer (20 mM Tris‐HCl, pH 7.5, 150 mM NaCl, 0.05% Tween‐20, 5% nonfat dried milk) for one hour at room temperature. Different organelle marker protein antibodies and other primary antibodies were then added and the proteins were incubated overnight at 4°C. The blot was washed with TBST (20 mM Tris‐HCl, 150 mM NaCl, 0.05% Tween‐20, pH 7.5). The films were scanned using the Powerlook scanner (UMAX Technologies, Dallas, TX, USA) and quantified by Image Quant software (TL 7.0).

Two‐dimensional differential in gel electrophoresis of mitochondria proteins {#tca13052-sec-0011}
----------------------------------------------------------------------------

The mitochondria‐enriched pellets were dissolved in lysis buffer (7 M urea, 2 M thiourea, 4% 3‐((3‐cholamidopropyl) dimethylammonio)‐1‐propanesulfonate \[CHAPS\], 30 mM Tris, 1 mM PMSF, pH8.5) at 4°C for one hour with intermittent sonication and then centrifuged at 20 000g for 30 minutes at 4°C. Protein extracts were purified using the Ettan 2D CleanUp kit (Amersham Biosciences) according to manufacturer\'s instructions, and adjusted to pH 8.5. The concentration of the total proteins was measured by using a 2D Quant kit (Amersham Biosciences).

The mitochondria protein lysates from two cell lines were labeled with Cy2, Cy3, and Cy5 following the protocols described in the Ettan DIGE User Manual (18‐1164‐40 Edition AA, GE Healthcare). Typically, 50 μg lysates were labeled with 400 pmol of Cy3 or Cy5, while the same amount of the pool standard of both samples was labeled with Cy2. We crossed fluorochromes between the pairs of analyzed samples to avoid differences resulting from the staining effectiveness. To achieve statistical confidence, three biological replicates were employed. Labeling reactions were carried out in the dark on ice for 30 minutes before quenching with 1 μL of 10 mM lysine for 10 minutes on ice. These labeled samples were then combined for 2D‐DIGE analysis.

Cy3 and Cy5 labeled samples (50 μg) were combined before mixing with 50 μg Cy2 labeled internal standards. An equal volume of 2× sample buffer (7 M urea, 2 M thiourea, 4% CHAPS, 30 mM Tris, 1 mM PMSF, 130 mM DTT, 2% IPG buffer) was added to the sample and the total volume was made up to 450 μL with rehydration buffer (7 M urea, 2 M thiourea, 2% CHAPS, 15 mM DTT, 0.5% IPG buffer). The proteins were applied to IPG strips (pH 3‐10, linear, 24 cm) and focused on an IPGphorIII (Amersham Biosciences) for a total of 64 kVH. The focused IPG strips were equilibrated and then applied to 12.5% SDS‐PAGE using low‐fluorescence glass plates on an Ettan DALT SIX system (Amersham Biosciences). All electrophoresis procedures were performed in the dark. After SDS‐PAGE, the gels were scanned on a Typhoon 9400 scanner (GE Healthcare) at appropriate excitation/emission wavelengths specific for Cy2 (488/520 nm), Cy3 (532/580 nm), and Cy5 (633/670 nm) to generate spot maps. We prepared another strip in parallel as a preparative gel for spot pickings using the same process, except the IPG strip was loaded with 1000 μg proteins and the gel was stained with Coomassie brilliant blue.

Imaging analysis {#tca13052-sec-0012}
----------------

DeCyder 6.5 software was used for 2D‐DIGE analysis, according to the manufacturer\'s recommendations. The DeCyder differential in‐gel analysis (DIA) module was used to compare each cell line mitochondria protein sample to the internal standard in each gel. The DeCyder biological variation analysis module was then used to simultaneously match all spot maps, using Cy3: Cy2 and Cy5: Cy2 DIA ratios, to calculate average abundance changes and Student\'s *t*‐test *P* values for the variance of these ratios for each protein across all samples. The differential protein spots (\|ratio\|NL9980/L9981 ≥ 1.2, *P* ≤ 0.05) were selected for identification.

Protein identification by mass spectrometry (MS) {#tca13052-sec-0013}
------------------------------------------------

Spots of interest were chosen using an Ettan Spot Picker from the preparative gel, destained, and digested with in‐gel trypsin. Tryptic peptides (0.5 μL) were mixed with 0.5 μL matrix solution (α‐cyano‐4‐hydroxycinnamic acid \[CHCA\] in 50% acetonitrile

\[ACN\]/0.1% trifluoroacetic acid \[TFA\]) and then analyzed using an AutoFlex MALDI‐TOF/TOF mass spectrometer with LIFT technology (Bruker Daltonics, Bremen, Germany) to obtain the peptide mass fingerprint. Peptide matching and protein searches against the NCBInr database were performed using the Mascot search engine (<http://www.matrixscience.com/>) with a mass tolerance of ±100 ppm.

Functional enrichment analyses of mitochondrial differential proteins and protein--protein interaction data {#tca13052-sec-0014}
-----------------------------------------------------------------------------------------------------------

The gene names of mitochondrial differential expression proteins were converted to NCBI‐Entrez format for consistency and saved as a text file that was input into Cytoscape version 3.0.2 ([www.cytoscape.org](http://www.cytoscape.org)), BiNGO plugin 3.0.2, and AgilentLiteratureSearch 3.0.3.beta downloaded from Cytoscape manage plugin was used to analyze the enriched biological processes, molecular functions, and literature based protein--protein interaction network studies.

RNA isolation, reverse transcription reaction, and real‐time PCR {#tca13052-sec-0015}
----------------------------------------------------------------

Total cellular RNA was isolated from 5 × 10^6^ cells using the Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer\'s instructions, and quantified using an ultraviolet spectrophotometer (Beckman Coulter, Fullerton, CA, USA).

RNA (2 μg) was reverse transcribed using an M‐MLV Reverse Transcriptase Kit (Promega) according to the manufacturer\'s protocol. Resultant cDNA (20 ng) was mixed with SYBR Green Master Mix (Applied Biosystems by Life Technologies, Foster City, CA, USA) and interest genes primer and amplified in the ABI7500 Real‐time PCR System according to the manufacturer\'s protocol. The results of relative quantification were analyzed by comparison of 2^−averageΔΔC^ ~T~ × 100%. The PCR primers are shown in Table [1](#tca13052-tbl-0001){ref-type="table"}.

###### 

Primers of real‐time PCR analysis

  Protein ID        Gene symbol   Forward Primer            Reverse Primer
  ----------------- ------------- ------------------------- ----------------------------
  1405              CAMSAP1       ATATGCTGTATGCGCCATTAGTG   GGGCTGAACAAAATCTGGCTT
  1451              MRPL1         GGAAGGCGAACCTGAGGATG      TGCCATATCCAGTGTCAAATCAA
  917               GLS           CACTCAAATCTACAGGATTGCGA   CTCCAGACTGCTTTTTAGCACTT
  1526              ATPAF1        TCAAATGTGTGGAACAGAAGACA   TGCGTAGACTGTATCTTTTGCTG
  799               ME 2          CTCTGTAACACCCGGCATATTAG   GGTGGGTAAAGTCTCCCTTGG
  1685              FAM82B        TCAGTTGCTAACCCAATACAAGG   CTCTTCTGAGGTTCTGCTAAGC
  1088              PDHA1         TCGCAGAGCTTACAGGACGA      ACTTACAGGCTAGAGCAATCCC
  1172              ACADM         GGAGATCACAGCATACAAAAGCC   TTAGGGGGACTGGATATTCACC
  1594              ABHD11        TCCGCTTTCCTACAGGCTTCT     GAAGAGCCCGTGCAAAAAGA
  1678              HSD17B10      AAGAAGTTAGGAAACAACTGCGT   CAGGCGGATCACATTGAAGGT
  1095              UQCRC1        CGGTGGGAGTGTGGATTGATG     GCCGATTCTTTGTTCCCTTGA
  923               DLD           GAAATGTCCGAAGTTCGCTTGA    TCAGCTTTCGTAGCAGTGACT
  923               SAMM50        CAAGTGGACCTGATTTTGGAGG    AGACGGAGCAATTTTTCACGG
  1563              COQ5          AGAGCTGGACTTGCATGGGTA     GGGGATTGTTCACTTGGCTAAAT
  1356              MRPL39        CCGACAGAATTGACAGAAATGCG   CTTCTCAGTTCGGGGAGTTAATG
  1606              AK2B          AAGCCTACCACACTCAAACCA     GCTTGCGAACACGACATCG
  740               MIPEP         TCTTACCAGAACACATTCGTCG    CTGCTGCTGAGCAATTCTTCTA
  1664              APOA1BP       GTGTCCTGAAGGGACTCACTG     CCCAGGTAATGGTAGCGACC
  1916              NDUFA5        AGGAAATCCCTAAAAATGCAGCA   TCTTCCACTAATGGCTCCCATA
  1660              UQCRFS1       TGCTTCTGTTTGTTATTCCCACA   AAACCTTTCCTAGCCTCGCTG
  1169              MRPL38        AACAGTGACATCGACTTGAGC     CCCGAAATACTCTCGGTAGGTC
  1301              TIMM50        GACGAAAATGGTGCCAAGAT      TAGGGTGGCTGGTAGTACGG
  1093              FH            ATGGTCTTGATCCAAAGATTGCT   TGATCCAGTCTGCCATACCAC
  1138              CS            CCATCCACAGTGACCATGAG      CTTTGCCAACTTCCTTCTGC
  1665              NDUFS3        ACTGTCAGACCACGGAATGAT     CCCTGAGGAAAGTCAGCACTG
  1932              ATP5J         GTTCTCCTCTGTCATTCGGTCA    CCAGCTCTTGCTGATACTCTGAA
  1553              PHB           GGCTGAGCAACAGAAAAAGG      GCTGGCAGGTAGGTGATGTT
  1586              AK2a          TGCAAGCCTACCACACTCAAA     GACATCGGGGGTCTGGGAT
  962               LAP3          CACACGTTTAACCCGAAGGT      AGAGAGGCATCCTCCAGACA
  1227              CECR5         CCACAGAGTGATCCCTGCTG      CGCTTCTCATGGTACTCGGA
  1589              DCI PROTEIN   AACCCCAGGTACTGCATAGGA     CAACCAGAAAGGGGCGATGAT
  1296              Coprox        AAGGCTGGGGTGAGCATTTC      GATTCTTGGGGTGGATAACAGAG
  971               ALDH7A1       TGGGCAGATATTCCTGCTCCA     CCCACACCTTCCACTAAGATTTT
  1717              PRDX3         GCCGTTGTCAATGGAGAGTTC     GCAAGATGGCTAAAGTGGGAA
  1139              NDUFS2        GGAGTCCGATTGCCGATTCAG     GGGCTGTTTCTTTGCTTGGG
  709               GPD2          TGAACCTGGCCTATGTTAAAGC    GGCTGTTTTTAGTCCTCTGGTG
  1756              SOD2          AACCTCAGCCCTAACGGTG       AGCAGCAATTTGTAAGTGTCCC
  Endogenous gene   GAPDH         AGCCGAGCCACATCGCT         GGCAACAATATCCACTTTACCAGAGT

GAPDH, glyceraldehyde 3‐phosphate dehydrogenase.

Statistical analysis {#tca13052-sec-0016}
--------------------

Data are presented as means ± standard deviation and the *t*‐test was used to analyze the differences between NL9980 and L9981 cell lines. *P* \< 0.05 was considered statistically significant. PCR and Western Blot analyses were repeated at least three times.

Results {#tca13052-sec-0017}
=======

Enrichment of mitochondrial fractions {#tca13052-sec-0018}
-------------------------------------

After protein extraction, we performed Western Blot analysis using cytochrome c, a mitochondrial marker, and PCNA, a nuclear marker. Cytochrome c was enriched while PCNA was barely detectable in the mitochondrial fraction, indicating that mitochondrial enrichment was not contaminated by proteins from other subcellular compartments (Fig [1](#tca13052-fig-0001){ref-type="fig"}).

![Representative Western blot analysis of mitochondria‐enriched fraction. PCNA was used as a nuclear marker and cytochrome c as a mitochondrial marker. Proteins (50 μg) were loaded per lane and detection was performed using electrochemiluminescence.](TCA-10-1111-g001){#tca13052-fig-0001}

Identification of differential proteins by MS {#tca13052-sec-0019}
---------------------------------------------

The mitochondria proteins of NL9980 and L9981 cell lines were compared by DIGE analysis and the mean number of spots detected in the three gels was 2333 ± 96.2 (Fig [2](#tca13052-fig-0002){ref-type="fig"}). Among 1722 ± 311.1 matched protein spots, 217 spots were differentially expressed in NL9980 and L9981 cell lines (\|ratio\| NL9980/ L9981 ≥ 1.2). Sixty‐four protein spots with the most remarkable alteration were further analyzed by MALDI‐TOF peptide fingerprint and their molecular functions were summarized (Table [2](#tca13052-tbl-0002){ref-type="table"}).

![Differential expression of mitochondrial proteins in NL9980 and L9981 cell lines. (**a--d**) DeCyder software output of typical two‐dimensional differential in gel electrophoresis images of the mitochondrial proteins in NL9980 and L9981 cell lines; the protein lysates are labeled with either Cy3 (green) or Cy5 (red), respectively. (**e**) Identification of differentially expressed proteins. (**f**--**g**) Three‐dimensional images of HSD17B10 and PRDX3, which show that HSD17B10 and PRDX3 levels are higher in NL9980 compared to L9981 cell lines (**f**) Results of matrix assisted laser desorption‐ionization‐time of flight mass spectrometry analysis of protein spots of HSD17B10 and PRDX3 by peptide mass fingerprinting analysis.](TCA-10-1111-g002){#tca13052-fig-0002}

###### 

Differentially expressed mitochondria proteins between NL9980 and L9981, identified by mass spectrometry

  Master No.   Accession No.   *t*‐test   Av. Ratio   Protein name                                                                                                                                                       Reported molecular function                                                                                                                                               Calculated PI value   Nominal mass (Mr)   Sequence covered (%)   Score
  ------------ --------------- ---------- ----------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------- ------------------- ---------------------- -------
  625          gi\|5822580     0.00074    −10.41      Chain A, crystal structure of the human Pax‐6 Paired domain‐DNA complex reveals a general model for Pax protein‐DNA interactions                                                                                                                                                                                                             9.86                  14 744              45                     66
  1405         gi\|186659512   0.00016    −8.63       CAMSAP1                                                                                                                                                            Cytoskeleton organization                                                                                                                                                 6.28                  179 230             6                      67
  1423         gi\|83405782    0.000085   −7.35       VEPH1                                                                                                                                                                                                                                                                                                                                        6.28                  90 436              9                      66
  1339         gi\|4324699     0.00019    −7.25       NUMA1                                                                                                                                                              Structural molecule activity, lung epithelial cell differentiation                                                                                                        10.56                 31 952              37                     68
  1324         gi\|4457970     0.000085   −7.01       tn88b03.x1 NCI_CGAP_Ut2 *Homo sapiens* cDNA clone IMAGE:2176589 3′, mRNA sequence                                                                                                                                                                                                                                                            9.46                  10 934              60                     92
  1490         gi\|77939099    0.0012     −6.53       MCF7RNAL18G24TF Human MCF7 breast cancer cell line near full length normalized library (MCF7_EST) Homo sapiens cDNA clone MCF7_RNA_L\_18_G24 mRNA sequence                                                                                                                                                                                   5.44                  19 514              34                     92
  1424         gi\|55666319    0.00024    −6.41       CASK (MAGUK family)                                                                                                                                                Glycogen biosynthetic process, protein amino acid phosphorylation, intracellular protein transport, cell adhesion                                                         5.83                  67 245              18                     74
  1831         gi\|5454090     0.0038     −6.37       SSR4                                                                                                                                                               Intracellular protein transport                                                                                                                                           5.76                  19 158              35                     111
  1170         gi\|77935996    0.000097   −6.32       MCF7RNAL16B02TR Human MCF7 breast cancer cell line near full length normalized library (MCF7_EST) Homo sapiens cDNA clone MCF7_RNA_L\_16_B02, mRNA sequence                                                                                                                                                                                  6.17                  23 959              42                     122
  1036         gi\|76827262    0.000097   −6.1        ETV2                                                                                                                                                               Regulation of transcription, DNA‐dependent                                                                                                                                9.16                  17 837              30                     67
  1420         gi\|34536332    0.000097   −5.54       GFAP                                                                                                                                                               Structural constituent of cytoskeleton                                                                                                                                    5.84                  49 533              12                     54
  1420         gi\|34782991    0.000097   −5.54       INPP5B                                                                                                                                                             Signal transduction, microtubule cytoskeleton, metal ion binding                                                                                                          5.44                  85 202              8                      54
  1451         gi\|74733472    0.00099    −4.16       MRPL1                                                                                                                                                              Translation, RNA binding, structural constituent of ribosome                                                                                                              8.19                  34 602              27                     78
  1629         gi\|49119653    0.00049    −1.67       YWHAZ                                                                                                                                                              Protein targeting mitochondrion, anti‐apoptosis, signal transduction                                                                                                      4.72                  30 100              38                     100
  1343         gi\|13786630    0.017      −1.58       Chain A, crystallographic structure of human branched chain amino acid aminotransferase (mitochondrial) complexed with PLP at 1.95 angstroms (orthorhombic form)   Valine, leucine, and isoleucine degradation and biosynthesis, pantothenate and CoA biosynthesis                                                                           8.48                  41 635              29                     94
  685          gi\|18677024    0.01       −1.24       PDE2                                                                                                                                                                                                                                                                                                                                         6.33                  59 567              31                     87
  685          gi\|50513540    0.01       −1.24       Chain A, Moesin FERM domain bound to EBP50 C‐terminal peptide                                                                                                      Regulation of lymphocyte migration                                                                                                                                        9.03                  35 010              32                     75
  917          gi\|6002671     0.00084    3.82        GAC                                                                                                                                                                Glutamine metabolic process                                                                                                                                               6.05                  58 678              17                     98
  1431         gi\|21361454    0.00032    3.25        PYCR2                                                                                                                                                              Amino acid biosynthetic process, electron transport                                                                                                                       7.66                  33 958              35                     116
  670          gi\|14149738    0.0032     2.8         Neurolysin                                                                                                                                                         Proteolysis                                                                                                                                                               6.21                  81 341              40                     200
  1526         gi\|110349780   0.0012     2.58        ATPAF1 isoform 1 precursor                                                                                                                                                                                                                                                                                                                   8.12                  36 756              33                     180
  799          gi\|4505145     0.00033    2.54        ME2, NAD(+)‐dependent, mitochondrial                                                                                                                               Malate metabolic process, metabolic process                                                                                                                               7.53                  66 029              37                     166
  1434         gi\|74733472    0.00026    2.45        MRPL1                                                                                                                                                              Translation, RNA binding, structural constituent of ribosome                                                                                                              8.19                  34 602              33                     84
  580          gi\|46249758    0.00026    2.39        Ezrin                                                                                                                                                              Epithelial cell differentiation, actin filament binding                                                                                                                   5.94                  69 313              28                     154
  1685         gi\|119612044   0.0045     2.39        FAM82B, isoform CRA_a                                                                                                                                              Binding                                                                                                                                                                   6.21                  31 180              20                     70
  1088         gi\|62897039    0.00085    2.36        PDC (lipoamide) alpha 1 variant                                                                                                                                    Acetyl‐CoA metabolic process, glycolysis, metabolic process                                                                                                               8.35                  43 934              40                     130
  1088         gi\|119572383   0.00085    2.36        TUFM‐1, isoform CRA_b                                                                                                                                              Cell proliferation, mitochondria translation                                                                                                                              6.14                  37 775              26                     54
  1172         gi\|4557231     0.00088    2.19        ACAD C‐4 to C‐12 straight chain isoform, a precursor                                                                                                               Electron transport, lipid metabolic process                                                                                                                               8.61                  47 015              44                     198
  1594         gi\|40226380    0.00024    2.19        ABHD11                                                                                                                                                             Proteolysis, aromatic compound metabolic process                                                                                                                          9.24                  34 310              28                     115
  1678         gi\|83715985    0.000097   2.12        HSD17B10 isoform 2                                                                                                                                                 Lipid metabolic, metabolic, enterobactin biosynthetic, and cellular metabolic processes                                                                                   6.73                  26 196              67                     142
  1095         gi\|46593007    0.00029    2.09        UQCRC1                                                                                                                                                             Electron transport, oxidative phosphorylation, proteolysis, transport, aerobic respiration                                                                                5.94                  53 297              35                     118
  923          gi\|62088 986   0.001      2.04        DLD, variant                                                                                                                                                       Electron transport, transfer RNA processing, cell redox homeostasis                                                                                                       8.71                  56 129              22                     99
  923          gi\|14043738    0.001      2.04        SAMM50                                                                                                                                                             Biological process                                                                                                                                                        6.44                  52 271              39                     133
  1563         gi\|116063536   0.00049    2.02        COQ5                                                                                                                                                               Ubiquinone biosynthetic process, metabolic process                                                                                                                        6.47                  37 402              45                     152
  736          gi\|62089196    0.0076     1.96        TRAP1                                                                                                                                                              Protein targeting                                                                                                                                                         8.32                  80 228              27                     123
  1356         gi\|33337737    0.0024     1.91        MRPL39                                                                                                                                                             TRAP1 variant                                                                                                                                                             8.00                  38 695              32                     138
  709          gi\|119631857   0.00085    1.91        GPD2 (mitochondrial), isoform CRA_a                                                                                                                                Glucose catabolic process, glycerol‐3‐phosphate metabolic process, gluconeogenesis, electron transport, insulinoma, non‐insulin‐dependent diabetes mellitus               7.23                  79 202              23                     97
  1606         gi\|7524346     0.0001     1.89        AK2 isoform b                                                                                                                                                      Nucleobase, nucleoside, nucleotide, and nucleic acid metabolic process                                                                                                    7.71                  25 769              43                     127
  740          gi\|156105687   0.0012     1.88        MIP                                                                                                                                                                Proteolysis, mitochondrial protein processing                                                                                                                             6.6                   81 357              19                     80
  1664         gi\|119573328   0.0017     1.88        APOA1 isoform CRA_c                                                                                                                                                Biological process                                                                                                                                                        5.27                  26 369              46                     118
  1302         gi\|46593007    0.0013     1.86        UQCRC1                                                                                                                                                             Electron transport, oxidative phosphorylation, proteolysis, transport, aerobic respiration                                                                                5.94                  53 297              42                     166
  1916         gi\|4826848     0.00018    1.86        NDUFA5                                                                                                                                                             Electron transport, mitochondrial electron transport, NADH to ubiquinone                                                                                                  5.75                  13 507              42                     124
  1660         gi\|45768728    0.000097   1.85        UQCRFS1                                                                                                                                                            Electron transport, transport                                                                                                                                             8.55                  29 958              29                     112
  1169         gi\|15342081    0.00032    1.84        MRPL38                                                                                                                                                                                                                                                                                                                                       6.2                   41 017              52                     200
  572          gi\|4505257     0.00037    1.79        Moesin                                                                                                                                                             Cell motility                                                                                                                                                             6.08                  67 892              29                     100
  1589         gi\|16307101    0.0025     1.69        DCI                                                                                                                                                                Lipid metabolism                                                                                                                                                          6.32                  27 250              32                     114
  1301         gi\|14290586    0.00024    1.69        TIMM50                                                                                                                                                             Protein amino acid dephosphorylation, mitochondrial membrane organization and biogenesis, protein transport, intracellular protein transport across a membrane            8.56                  39 014              38                     190
  1093         gi\|19743875    0.00055    1.66        FH precursor                                                                                                                                                       Tricarboxylic acid cycle, fumarate metabolic process, cell cycle, negative regulation of progression, homeostasis of number of cells within a tissue through cell cycle   8.85                  54 773              33                     158
  1139         gi\|4758786     0.00065    1.66        NDUFS2                                                                                                                                                             Electron transport, mitochondrial electron transport, NADH to ubiquinone, response to oxidative stress                                                                    7.21                  52 911              27                     105
  1138         gi\|48257138    0.00091    1.65        Citrate synthase                                                                                                                                                   Carbohydrate metabolic process, tricarboxylic acid cycle                                                                                                                  6.49                  45 758              18                     82
  1665         gi\|5138999     0.0015     1.65        NADH‐Ubiquinone reductase                                                                                                                                          Electron transport, mitochondrial electron transport, NADH to ubiquinone, oxygen and reactive oxygen, pathogenesis, induction of apoptosis species metabolic process      7.77                  30 401              51                     252
  1932         gi\|18644883    0.0036     1.65        ATP5PF, mitochondrial isoform a precursor                                                                                                                          Generation of precursor metabolites and energy, ion transport, ATP synthesis‐coupled proton transport, proton transport                                                   9.52                  12 580              54                     94
  1553         gi\|4505773     0.0011     1.64        PHB                                                                                                                                                                Regulation of progression through cell cycle, DNA replication, signal transduction, negative regulation of cell proliferation, negative regulation of transcription       5.57                  29 843              41                     162
  1586         gi\|4502013     0.000097   1.64        AK2 isoform A                                                                                                                                                      Nucleobase, nucleoside, nucleotide, and nucleic acid metabolic process                                                                                                    7.67                  26 689              35                     104
  1142         gi\|704416      0.0081     1.62        EF‐Tu                                                                                                                                                              DNA/RNA/protein synthesis                                                                                                                                                 7.7                   49 851              3                      37
  971          gi\|116241244   0.0007     1.61        ALDH7A1                                                                                                                                                            Aldehyde dehydrogenase (NAD) activity, L‐aminoadipate‐semialdehyde dehydrogenase activity, oxidoreductase activity                                                        6.44                  55 845              25                     73
  1227         gi\|21914862    0.00038    1.54        CECR5                                                                                                                                                              3.33333E+13                                                                                                                                                               6.43                  43 845              41                     129
  1717         gi\|119569781   0.00043    1.53        PRDX3, isoform CRA_a                                                                                                                                               Activation of NF‐kappaB transcription factor                                                                                                                              5.73                  24 941              49                     84
  1296         gi\|433888      0.0026     1.48        CPOX                                                                                                                                                               Porphyrin and chlorophyll metabolism                                                                                                                                      6.68                  40 847              53                     238
  986          gi\|122065129   0.0057     1.4         ALDH3B1 (ALDH class 2)                                                                                                                                             Glycolysis/gluconeogenesis                                                                                                                                                6.36                  57 658              24                     133
  962          gi\|37588925    0.00079    1.39        LAP3                                                                                                                                                               3.33333E+13                                                                                                                                                               6.80                  54 754              49                     197
  973          gi\|119577249   0.019      1.31        SARS2, isoform CRA_b                                                                                                                                                                                                                                                                                                                         8.80                  61 018              33                     123
  973          gi\|119595468   0.019      1.31        NARS2 (mitochondrial) (putative), isoform CRA_b                                                                                                                                                                                                                                                                                              6.79                  53 699              15                     66
  1756         gi\|38503339    0.0018     1.26        SOD \[Mn\], mitochondrial                                                                                                                                          Superoxide dismutase activity, manganese superoxide dismutase activity, oxidoreductase activity, manganese ion binding, metal ion binding                                 6.86                  22 304              43                     93

*T*‐test and Av. Ratio:NL9980/L9981.

Functional enrichment analyses of mitochondrial differential proteins and protein--protein interaction data {#tca13052-sec-0020}
-----------------------------------------------------------------------------------------------------------

Functional enrichment category analyses of mitochondrial differential proteins were identified. The functional enrichment maps of the biological process and molecular function are shown in Figures [3](#tca13052-fig-0003){ref-type="fig"} and [4](#tca13052-fig-0004){ref-type="fig"}, respectively. The white color shows non‐significance in enrichment analysis; the color range from yellow to orange shows an adjusted *P* value from 0.05 to \< 5\*10‐7. The statistical significantly enriched biological processes and molecular functions (*P* \< 0.05, adjusted using the Bonferroni correction) are listed in Table [3](#tca13052-tbl-0003){ref-type="table"}. Biological processes, such as cellular respiration, energy derivation by oxidation of organic compounds, electron transport chain, respiratory electron transport chain, cellular metabolic process, generation of precursor metabolites and energy, oxidation reduction, and the metabolic process were enriched. Molecular functions, such as oxidoreductase and catalytic activity, were also enriched. The results showed that most of enriched proteins of the identified mitochondrial differential proteins were oxidoreduction‐related proteins and biological processes were oxidoreduction‐related processes.

![Enriched biological processes of differentially expressed mitochondrial proteins between NL9980 and L9981 cell lines with low and high metastatic potential. Color circles represent biological processes, arrows represent the relationship between two biological processes, white circles show non‐significance in enrichment analysis, and the color range from yellow to orange shows adjusted *P* values from 0.05 to \< 5\*10‐7.](TCA-10-1111-g003){#tca13052-fig-0003}

![Enriched molecular functions of differentially expressed mitochondrial proteins between NL9980 and L9981 cell lines with low and high metastatic potential. Color circles represent molecular functions, arrows represent the relationship between two molecular functions, white circles show non‐significance in enrichment analysis, and the color range from yellow to orange shows adjusted *P* values from 0.05 to \< 5\*10‐7.](TCA-10-1111-g004){#tca13052-fig-0004}

###### 

Functional enrichment category analyses of mitochondrial differential proteins

  GO ID                GO term                                                          *P*         Number of genes
  -------------------- ---------------------------------------------------------------- ---------- -----------------
  Biological Process                                                                               
  6732                 Coenzyme metabolic process                                       2.75E‐03           6
  6082                 Organic acid metabolic process                                   1.81E‐03          10
  45333                Cellular respiration                                             1.35E‐07           8
  7005                 Mitochondrion organization                                       1.07E‐03           6
  15980                Energy derivation by oxidation of organic compounds              3.68E‐06           8
  22900                Electron transport chain                                         1.85E‐05           7
  22904                Respiratory electron transport chain                             1.62E‐05           6
  19752                Carboxylic acid metabolic process                                1.62E‐03          10
  42180                Cellular ketone metabolic process                                2.25E‐04          11
  42773                ATP synthesis coupled electron transport                         3.40E‐04           5
  43648                Dicarboxylic acid metabolic process                              3.72E‐03           4
  44237                Cellular metabolic process                                       2.92E‐05          31
  51186                Cofactor metabolic process                                       9.28E‐04           7
  6091                 Generation of precursor metabolites and energy                   4.03E‐07          11
  44281                Small molecule metabolic process                                 1.31E‐03          15
  6119                 Oxidative phosphorylation                                        2.45E‐04           6
  55114                Oxidation reduction                                              3.92E‐09          16
  43436                Oxoacid metabolic process                                        1.62E‐03          10
  42775                Mitochondrial ATP synthesis coupled electron transport           3.40E‐04           5
  8152                 Metabolic process                                                1.31E‐05          34
  6120                 Mitochondrial electron transport, NADH to ubiquinone             4.09E‐03           4
  Molecular Function                                                                               
  51287                NAD or NADH binding                                              1.83E‐03           4
  16903                Oxidoreductase activity, acting on the aldehyde or oxo           2.10E‐02           3
  16681                Oxidoreductase activity, acting on diphenols and its analogues   4.35E‐02           2
  8137                 NADH dehydrogenase (ubiquinone) activity                         4.98E‐02           3
  8121                 Ubiquinol‐cytochrome‐c reductase activity                        4.35E‐02           2
  16491                Oxidoreductase activity                                          2.34E‐09          16
  3954                 NADH dehydrogenase activity                                      4.98E‐02           3
  50136                NADH dehydrogenase (quinone) activity                            4.98E‐02           3
  3824                 Catalytic activity                                               2.55E‐06          32
  16651                Oxidoreductase activity, acting on NADH or NADPH                 6.29E‐04           5
  50662                Coenzyme binding                                                 2.65E‐02           5

GO, gene ontology.

A literature based protein--protein interaction subnetwork of mitochondrial differential proteins was generated using AgilentLiteratureSearch from CytoScape. The results are shown in Figure [5](#tca13052-fig-0005){ref-type="fig"}. In this subnetwork, the colored circles (nodes) represent proteins, the yellow circles represent the proteins from our results, and the grey full lines (edges) represent protein--protein interactions. Mitochondrial differential proteins, such as PRDX3, SOD2, PHB, HSP75 (TRAP1) and GLS, more frequently interacted with other proteins. These interaction data provide important insight into the molecular mechanisms of NSCLC metastasis.

![A protein--protein interaction subnetwork of differentially expressed mitochondrial proteins between NL9980 and L9981 cell lines with low and high metastatic potential. In this subnetwork, the colored circles (nodes) represent proteins, the yellow circles represent the proteins from our results, and the grey full lines (edges) represent protein--protein interactions.](TCA-10-1111-g005){#tca13052-fig-0005}

Validation of differentially expressed proteins on gene level by real‐time PCR {#tca13052-sec-0021}
------------------------------------------------------------------------------

To verify the 2D‐DIGE profiling results, we selected 37 genes and detected their expression by real time PCR. The genetic alterations of selected mitochondria proteins conformed to the 2D‐DIGE data (Fig [6](#tca13052-fig-0006){ref-type="fig"}).

![Real‐time PCR analysis of differentially expressed mitochondrial proteins. After two‐dimensional differential in gel electrophoresis analysis, 37 genes were further tested by real‐time PCR. The relative gene expression of NL9980 cells compared to L9981 cells is shown.](TCA-10-1111-g006){#tca13052-fig-0006}

Validation of differentially expressed proteins by Western blotting {#tca13052-sec-0022}
-------------------------------------------------------------------

To further validate the 2D‐DIGE profiling result from protein level, we performed Western blot analysis on several interesting mitochondrial proteins, including FH, PRDX3, HSP75, ERAB, and PHB. The expression of recruited proteins was significantly higher in NL9980 cells compared to L9981 cells, which was consistent with results from the 2D‐DIGE data (Fig [7](#tca13052-fig-0007){ref-type="fig"}).

![Validation of differentially expressed mitochondrial proteins by Western blot analysis. The expression of FH, PRDX3, HSP75, ERAB, and PHB proteins between NL9980 and L9981 cell lines were further validated by Western blot analysis. COX IV was used as an internal control for equal protein loading. One representative result out of three independent experiments is shown.](TCA-10-1111-g007){#tca13052-fig-0007}

Discussion {#tca13052-sec-0023}
==========

To a large extent, the poor prognosis of lung cancer is associated with its malignant metastatic phenotype. To better explore and understand the mechanism of lung cancer metastasis and to search for potential markers for early diagnosis and reverse metastasis, we previously performed differential proteomic analysis in two human large cell lung cancer cell lines with high (L9981) and low (NL9980) metastasis potential by 2D‐DIGE. The data suggest that obvious differential proteomic expression exists between human high and low metastatic large cell lung cancer cell lines.[44](#tca13052-bib-0044){ref-type="ref"} Although the molecular mechanisms have gradually been deciphered, the function of mitochondria in the process of lung cancer metastasis remains unknown. Some studies have demonstrated that in certain tumors, such as nasopharyngeal and hepatocellular carcinoma, mitochondrial proteins are the potential biomarkers for cancer initiation and progression.[45](#tca13052-bib-0045){ref-type="ref"}, [46](#tca13052-bib-0046){ref-type="ref"}, [47](#tca13052-bib-0047){ref-type="ref"} Therefore, we proposed that mitochondrial proteins might be differentially expressed in lung cancer metastasis.

Routine protein analysis to detect mitochondrial proteins is difficult because of their low expression compared to non‐mitochondrial proteins. In this study, we conducted 2D‐DIGE analysis combined with MALDI‐TOF/TOF to evaluate the differences in mitochondrial protein expression between two human large cell lung cancer cell lines with high (L9981) and low (NL9980) metastatic potential. Two dimensional‐DIGE revealed 217 differential spots between the two cell lines, while MS revealed a further 64 spots with significant differences. Interestingly, a number of non‐mitochondrial proteins that presented in the enriched mitochondria fraction were also differentially expressed between the two cell lines. These proteins are either peripherally associated with the mitochondria, sublocated in the mitochondria, or present as possible contaminants in the preparation. Nevertheless, according to Swiss‐Prot annotation, the majority of the differentially expressed proteins were localized in the mitochondria. Among these candidates, six proteins piqued our interest, including FH, HSP75, ERAB, PHB, and PRDX3, which have previously been reported to be involved in cancer development and metastasis.

Loss‐of‐function of FH, a metabolic tumor suppressor, is associated with hereditary leiomyomatosis and renal cell carcinoma.[49](#tca13052-bib-0049){ref-type="ref"} Studies have shown that FH‐deficient cancer is characterized by impaired oxidative phosphorylation and a metabolic shift to aerobic glycolysis, a form of metabolic reprogramming referred to as the Warburg effect. These changes represent multiple biochemical adaptations in the glucose and fatty acid metabolism that supports malignant proliferation.[50](#tca13052-bib-0050){ref-type="ref"}, [51](#tca13052-bib-0051){ref-type="ref"} To date, no reports have identified the relevance of FH in lung cancer development and metastasis; however, in our study, we observed that L9981 cells showed significantly low expression of FH compared to NL9980 cells. As FH is reported to be a metabolic tumor suppressor, we assumed that FH might negatively regulate lung cancer invasion and metastasis.

HSP75, also called tumor necrosis factor type 1 receptor‐associated protein (TRAP‐1), is another downregulated mitochondrial protein with high metastatic ability in L9981 cells. HSP75 is a negative regulator of mitochondrial respiration that can modulate the balance between oxidative phosphorylation and aerobic glycolysis. The impact of HSP75 on mitochondrial respiration is probably mediated by the modulation of mitochondrial spare respiratory capacity (SRC) and the inhibition of *SDHA*. Previous studies have indicated that HSP75 expression is significantly reduced in bladder cancer and renal cell carcinoma compared to healthy tissues, but is increased in other types of tumors.[52](#tca13052-bib-0052){ref-type="ref"}, [53](#tca13052-bib-0053){ref-type="ref"}, [54](#tca13052-bib-0054){ref-type="ref"} Recently, Agorreta *et al.* reported that HSP75 impacts the viability of NSCLC cells, and that its expression is prognostic in NSCLC.[55](#tca13052-bib-0055){ref-type="ref"} Liu *et al.* confirmed that HSP75 could stimulate the proliferation of lung cancer cells but inhibits metastatic spread.[56](#tca13052-bib-0056){ref-type="ref"} However, Caino *et al.* reported contradictory findings, reporting that HSP75 favors metastatic dissemination in disease models in mice, and shortens overall survival in patients with NSCLC,[57](#tca13052-bib-0057){ref-type="ref"} indicating that the role of HSP75 is complex in lung cancer metastasis.

ERAB is characterized as a NAD +‐dependent dehydrogenase that is constitutively expressed in tissues and overexpressed in neurons affected in Alzheimer\'s disease. Cells overexpressing ERAB in vitro are more sensitive to β‐Amyloid‐induced stress, and blocking ERAB activity has been shown to inhibit this cell death, indicating that β‐Amyloid induced cell death is mediated by ERAB.[58](#tca13052-bib-0058){ref-type="ref"}, [59](#tca13052-bib-0059){ref-type="ref"} The role of ERAB in tumors has rarely been reported. The only study we located by Shen *et al.* indicated that ERAB is differentially expressed in HOXA13 knockdown esophageal squamous cell carcinoma cells.[60](#tca13052-bib-0060){ref-type="ref"}

PHB is an evolutionary conserved protein that responds to mitochondrial stress and plays a role in regulating mitochondrial respiration activity.[61](#tca13052-bib-0061){ref-type="ref"} It is considered a regulator of cell growth, proliferation, differentiation, aging, and apoptosis.[62](#tca13052-bib-0062){ref-type="ref"} The role of PHB in cancer cell growth remains controversial. Many reports have shown evidence that PHB overexpression results in the inhibition of cancer cell growth, but the knockdown of PHB by small interfering RNA (siRNA) accelerates tumor growth in prostate, gastric, and liver cancers.[63](#tca13052-bib-0063){ref-type="ref"}, [64](#tca13052-bib-0064){ref-type="ref"}, [65](#tca13052-bib-0065){ref-type="ref"} However, other studies have suggested that PHB plays a protumorigenic role. PHB is necessary for the activation of C‐Raf by the oncogene Ras in HeLa cells.[66](#tca13052-bib-0066){ref-type="ref"} In the present study, L9981 cells showed slightly decreased expression of PHB compared to NL9980 cells. The exact of role of PHB in lung cancer metastasis remains under investigation.

PRDX3 functions as an antioxidant and is localized in the mitochondrion. PRDX3 overexpression is associated with the cancer development, progression, and drug resistance. Results suggest that PRDX3 is upregulated in prostate cancer and plays an essential role in regulating oxidation‐induced apoptosis in anti‐androgen‐resistant prostate cancer cells.[67](#tca13052-bib-0067){ref-type="ref"}, [68](#tca13052-bib-0068){ref-type="ref"} Moreover, PRDX3 is reported to be involved in drug resistance in ovarian cancer. Wang *et al.* reported that PRDX3 protein expression is significantly higher in platinum‐resistant ovarian cancer patients than in platinum‐sensitive patients.[69](#tca13052-bib-0069){ref-type="ref"} Recently, Duan *et al.* further demonstrated that downregulation of PRDX3 by siRNA enhanced cisplatin induced ovarian cancer cell apoptosis, providing new evidence of the potential application of PRDX3‐siRNA in cancer therapy.[70](#tca13052-bib-0070){ref-type="ref"} Regarding PRDX3 lung cancer, Kim *et al.* showed that PRDX3 was markedly overexpressed in human squamous cell carcinoma, suggesting that it may play a protective role against oxidative injury in lung cancer.[71](#tca13052-bib-0071){ref-type="ref"} Our mRNA and protein level results confirm that PRDX3 expression is remarkably decreased in high metastatic lung cancer L9981 compared to low metastatic lung cancer NL9980 cell lines, indicating that PRDX3 might also be involved in the lung cancer metastatic process.

In summary, for the first time, we have identified mitochondrial differential expression profiling between lung cancer cells with high and low metastatic potential by screening mitochondrial protein expression. Further investigation is necessary to determine the biological function and the relevance of the identified mitochondrial proteins in the metastatic process of lung cancer.
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